AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases

Taiyu Shanga,1, Tianyi Jiangb,c,1, Xiaowen Cuib, Yufei Panb, Xiaofan Fengb,c, Liwei Dongb,c( ), Hongyang Wanga,b,c,d ( )
School of Life Sciences, Institute of Metabolism and Integrative Biology, Fudan University, Shanghai 200438, China
National Center for Liver Cancer, The Naval Medical University, Shanghai 201805, China
International Cooperation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, The Second Military Medical University, Shanghai 200438, China
Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Second Military Medical University & Ministry of Education, Shanghai 200438, China

1 These authors contributed equally to this work.

Peer review under responsibility of Chongqing Medical University.

Show Author Information

Abstract

The liver is the central organ for digestion and detoxification and has unique metabolic and regenerative capacities. The hepatobiliary system originates from the foregut endoderm, in which cells undergo multiple events of cell proliferation, migration, and differentiation to form the liver parenchyma and ductal system under the hierarchical regulation of transcription factors. Studies on liver development and diseases have revealed that SRY-related high-mobility group box 9 (SOX9) plays an important role in liver embryogenesis and the progression of hepatobiliary diseases. SOX9 is not only a master regulator of cell fate determination and tissue morphogenesis, but also regulates various biological features of cancer, including cancer stemness, invasion, and drug resistance, making SOX9 a potential biomarker for tumor prognosis and progression. This review systematically summarizes the latest findings of SOX9 in hepatobiliary development, homeostasis, and disease. We also highlight the value of SOX9 as a novel biomarker and potential target for the clinical treatment of major liver diseases.

References

【1】
【1】
 
 
Genes & Diseases
Article number: 100996

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Shang T, Jiang T, Cui X, et al. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases. Genes & Diseases, 2024, 11(4): 100996. https://doi.org/10.1016/j.gendis.2023.03.035

1144

Views

9

Downloads

13

Crossref

11

Web of Science

11

Scopus

2

CSCD

Received: 26 July 2022
Revised: 13 February 2023
Accepted: 19 March 2023
Published: 24 June 2023
© 2023 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).